Reprise Biomedical, founded in June 2019 as a spin-off from Miromatrix Medical Inc., is a Minnesota-based startup dedicated to commercializing biological medical devices. The company leverages proprietary perfusion decellularization technology to create products that support rapid cellular integration. Their product lineup includes Miro3D, MiroDerm, MiroTract, and MiroFlex, all designed to provide advanced solutions for healing, particularly for deep and tunneling wounds.
Notable figures associated with Reprise Biomedical include key personnel from Miromatrix Medical Inc., who played a significant role in the company's inception. The startup has garnered attention for its innovative approach to medical device manufacturing, achieving significant milestones in product development and market penetration. Reprise Biomedical's impact is evident in its contribution to advancing wound care technology, offering effective and efficient healing solutions that address complex medical needs.